Silencing ATF4/SPHK1 signaling re-established sensitivity of GBM cells to TMZ treatment, as evidenced by induction of apoptosis and inhibition of migration and invasion in the GBM cells. This evidence concerns the gene SPHK1 and glioblastoma.